Cancer Incidence for the City of Syracuse, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Males and Females | Males | Females | ||||||
---|---|---|---|---|---|---|---|---|---|
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 712.6 | 479.0 | 462.8-495.7 | 371.2 | 554.8 | 528.9-581.7 | 341.4 | 424.3 | 403.3-446.1 |
Oral cavity and pharynx | 21.6 | 14.7 | 12.0-17.9 | 13.0 | 19.3 | 14.7-24.8 | 8.6 | 11.0 | 7.8-15.1 |
Esophagus | 6.8 | 4.5 | 3.1-6.3 | 5.8 | 8.3 | 5.5-12.1 | 1.0 | 1.4 | 0.4-3.3 |
Stomach | 11.6 | 7.6 | 5.7-10.0 | 9.2 | 14.5 | 10.5-19.5 | 2.4 | 2.6 | 1.3-4.8 |
Colorectal | 53.0 | 35.4 | 31.1-40.2 | 28.2 | 42.7 | 35.7-50.6 | 24.8 | 29.7 | 24.4-35.8 |
Colon excluding rectum | 38.4 | 25.6 | 21.9-29.6 | 21.6 | 32.7 | 26.6-39.7 | 16.8 | 19.8 | 15.5-24.8 |
Rectum & rectosigmoid | 14.6 | 9.8 | 7.6-12.5 | 6.6 | 10.0 | 6.8-14.2 | 8.0 | 9.9 | 6.9-13.7 |
Liver / intrahepatic bile duct | 19.0 | 11.7 | 9.4-14.4 | 14.8 | 20.0 | 15.5-25.3 | 4.2 | 4.9 | 3.0-7.6 |
Pancreas | 21.0 | 13.6 | 11.0-16.5 | 10.6 | 16.1 | 11.9-21.3 | 10.4 | 11.2 | 8.3-14.9 |
Larynx | 9.8 | 6.6 | 4.9-8.8 | 7.6 | 11.3 | 7.9-15.7 | 2.2 | 2.8 | 1.4-5.1 |
Lung and bronchus | 129.8 | 85.3 | 78.6-92.3 | 65.8 | 100.5 | 89.6-112.4 | 64.0 | 74.3 | 66.2-83.1 |
Melanoma of the skin | 11.2 | 8.1 | 6.0-10.6 | 5.4 | 9.1 | 5.9-13.3 | 5.8 | 7.7 | 5.0-11.3 |
Female breast | 84.0 | 109.9 | 99.1-121.5 | ||||||
Cervix uteri | 5.6 | 7.8 | 5.0-11.4 | ||||||
Corpus uterus and NOS | 23.0 | 28.5 | 23.3-34.5 | ||||||
Ovary | 6.4 | 8.6 | 5.7-12.4 | ||||||
Prostate | 99.8 | 139.0 | 126.7-152.3 | ||||||
Testis | 2.4 | 3.5 | 1.7-6.4 | ||||||
Urinary bladder (incl. in situ) | 32.6 | 21.4 | 18.1-25.1 | 25.8 | 40.6 | 33.7-48.5 | 6.8 | 7.5 | 5.1-10.7 |
Kidney and renal pelvis | 28.2 | 20.1 | 16.8-23.8 | 19.0 | 29.1 | 23.3-36.0 | 9.2 | 12.3 | 8.9-16.5 |
Brain and other central nervous system | 7.8 | 5.4 | 3.8-7.5 | 4.0 | 6.1 | 3.6-9.5 | 3.8 | 4.8 | 2.8-7.7 |
Thyroid | 16.4 | 11.9 | 9.3-14.9 | 3.2 | 4.6 | 2.6-7.6 | 13.2 | 19.0 | 14.4-24.5 |
Hodgkin lymphoma | 5.0 | 3.6 | 2.3-5.5 | 2.4 | 4.0 | 2.0-7.1 | 2.6 | 3.3 | 1.7-5.9 |
Non-Hodgkin lymphomas | 27.4 | 18.8 | 15.6-22.4 | 14.2 | 22.4 | 17.3-28.5 | 13.2 | 15.9 | 12.0-20.6 |
Myeloma | 13.8 | 10.4 | 8.0-13.2 | 6.2 | 10.7 | 7.2-15.3 | 7.6 | 10.2 | 7.1-14.2 |
Leukemias | 21.6 | 14.5 | 11.8-17.7 | 9.4 | 14.6 | 10.5-19.6 | 12.2 | 14.5 | 10.9-19.0 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.